<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Endocrine Drugs (Part B) - Pharmacology and Pharmacotherapeutics</title>
    
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <link rel="stylesheet" href="../styles/main.css">
    
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams'
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <!-- Floating Table of Contents -->
    <div class="floating-toc" id="floating-toc">
        <div class="floating-toc-header">
            <span>üìë</span>
            <span>Contents</span>
        </div>
        <ul class="floating-toc-list">
            <!-- JS will populate this -->
        </ul>
    </div>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                <header class="document-header">
                    <div class="header-badge">
                        <span>‚öõÔ∏è</span>
                        <span>Section XIII (Part B)</span>
                    </div>
                    <h1 class="document-title">Reproductive Hormones and Bone Metabolism</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Sex Steroids, Contraception, Androgens & Calcium</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>75 min read</span>
                        </div>
                    </div>
                </header>

                <main id="main-content" class="content-wrapper">
                    <!-- START: Chapter 67 -->
                    <section class="content-section" id="chapter-67">
                        <div class="section-header">
                            <div class="section-number">67</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚ôÄÔ∏è</span>
                                Gonadotropins, Estrogens and Progestins
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Gonadotropins and GnRH</h3>
                            <p><strong>GnRH Analogues (Gonadorelin, Leuprolide, Goserelin):</strong>
                            <br><strong>Mechanism:</strong> Pulsatile administration stimulates gonadotropin release. Continuous administration causes receptor downregulation and inhibition of FSH/LH release (Medical Castration).
                            <br><strong>Uses:</strong> Prostate cancer (continuous), Endometriosis, Precocious puberty, IVF (to prevent LH surge).</p>

                            <p><strong>Gonadotropins (FSH, LH, hCG):</strong>
                            <br><strong>Uses:</strong> Induction of ovulation (Infertility), Cryptorchism (hCG), Hypogonadotropic hypogonadism.</p>

                            <h3>Estrogens</h3>
                            <p><strong>Natural:</strong> Estradiol, Estrone, Estriol.
                            <br><strong>Synthetic:</strong> Ethinyl estradiol (Oral), Mestranol, Diethylstilbestrol (Non-steroidal).
                            <br><strong>Actions:</strong> Growth of genital tract, secondary sex characteristics, feedback regulation of GnRH, maintenance of bone mass (inhibit osteoclasts), favorable lipid profile (HDL $\uparrow$, LDL $\downarrow$).</p>
                            <p><strong>Therapeutic Uses:</strong>
                            <br>1. <strong>Hormone Replacement Therapy (HRT):</strong> For menopausal symptoms (hot flushes, vaginitis) and osteoporosis prevention.
                            <br>2. <strong>Contraception:</strong> Combined with progestins.
                            <br>3. <strong>Primary Hypogonadism:</strong> Turner's syndrome.</p>
                            
                            <div class="callout callout--warning">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ö†Ô∏è</span>
                                    <h4 class="callout-title">Estrogen Adverse Effects</h4>
                                </div>
                                <div class="callout-content">
                                    <p>Nausea, fluid retention, <strong>Thromboembolism</strong> (DVT, PE), increased risk of endometrial cancer (if used without progestin), breast tenderness, gallstones.</p>
                                </div>
                            </div>

                            <h3>SERMs (Selective Estrogen Receptor Modulators)</h3>
                            <p>Compounds with tissue-selective estrogen agonist or antagonist activity.</p>
                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Drug</th>
                                            <th>Agonist Effect</th>
                                            <th>Antagonist Effect</th>
                                            <th>Clinical Use</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Clomiphene</strong></td>
                                            <td>-</td>
                                            <td>Hypothalamus/Pituitary</td>
                                            <td>Induction of Ovulation (blocks negative feedback).</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Tamoxifen</strong></td>
                                            <td>Bone, Endometrium</td>
                                            <td>Breast</td>
                                            <td>Estrogen-receptor positive <strong>Breast Cancer</strong>.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Raloxifene</strong></td>
                                            <td>Bone</td>
                                            <td>Breast, Uterus</td>
                                            <td><strong>Osteoporosis</strong> in postmenopausal women.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Ormeloxifene</strong> (Centchroman)</td>
                                            <td>Bone</td>
                                            <td>Uterus</td>
                                            <td>Oral Contraceptive (Saheli), DUB.</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <h3>Progestins</h3>
                            <p><strong>Natural:</strong> Progesterone.
                            <br><strong>Synthetic:</strong> Medroxyprogesterone acetate (MPA), Norethisterone, Levonorgestrel, Desogestrel.
                            <br><strong>Uses:</strong> Contraception, DUB, Endometriosis, Endometrial cancer, HRT (to protect endometrium).</p>
                            <p><strong>Antiprogestin (Mifepristone/RU-486):</strong>
                            <br>Used for medical termination of pregnancy (with Misoprostol) and as emergency contraception.</p>
                        </div>
                    </section>
                    <!-- END: Chapter 67 -->

                    <!-- START: Chapter 68 -->
                    <section class="content-section" id="chapter-68">
                        <div class="section-header">
                            <div class="section-number">68</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíä</span>
                                Antifertility Agents
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Hormonal Contraceptives</h3>

                            <h4>1. Combined Oral Contraceptives (COC)</h4>
                            <p>Contains Estrogen (Ethinyl estradiol) + Progestin. Taken for 21 days with 7 days gap.
                            <br><strong>Mechanism:</strong>
                            <br>1. <strong>Inhibit Ovulation:</strong> Suppression of FSH and LH surge.
                            <br>2. <strong>Cervical Mucus:</strong> Makes it thick and hostile to sperm.
                            <br>3. <strong>Endometrium:</strong> Makes it unsuitable for implantation.
                            <br><strong>Contraindications:</strong> History of thromboembolism, stroke, breast cancer, liver disease, heavy smokers >35 years.</p>

                            <h4>2. Progestin Only Pills (POP / Mini-pills)</h4>
                            <p>Contains only progestin (e.g., Norethisterone). Taken continuously.
                            <br><strong>Mechanism:</strong> Mainly cervical mucus thickening and endometrial atrophy. Ovulation inhibited in only 50%.
                            <br><strong>Indication:</strong> Lactating women (estrogens suppress milk).</p>

                            <h4>3. Emergency Contraception ("Morning After" Pill)</h4>
                            <p>Used within 72 hours of unprotected intercourse.
                            <br><strong>Levonorgestrel:</strong> 1.5 mg single dose (or 0.75 mg x 2 doses).
                            <br><strong>Ulipristal:</strong> Selective progesterone receptor modulator. Effective up to 5 days.
                            <br><strong>Mifepristone:</strong> Antiprogestin.</p>

                            <h4>4. Injectables and Implants</h4>
                            <p><strong>DMPA (Depot Medroxyprogesterone Acetate):</strong> IM every 3 months.
                            <br><strong>NET-EN:</strong> IM every 2 months.
                            <br><strong>Implants (Norplant):</strong> Subcutaneous levonorgestrel rods (5 years).</p>
                        </div>
                    </section>
                    <!-- END: Chapter 68 -->

                    <!-- START: Chapter 69 -->
                    <section class="content-section" id="chapter-69">
                        <div class="section-header">
                            <div class="section-number">69</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚ôÇÔ∏è</span>
                                Androgens, Anabolic Steroids and Antiandrogens
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Androgens</h3>
                            <p><strong>Testosterone:</strong> Natural androgen. High first pass metabolism (ineffective orally).
                            <br><strong>Preparations:</strong> Testosterone enanthate/cypionate (IM depot), Methyltestosterone (Oral - hepatotoxic), Transdermal patches/gels.
                            <br><strong>Uses:</strong> Hypogonadism (Replacement), Delayed puberty.</p>

                            <h3>Anabolic Steroids</h3>
                            <p><strong>Nandrolone, Oxandrolone, Stanozolol.</strong>
                            <br>Synthetic derivatives with higher anabolic:androgenic ratio.
                            <br><strong>Uses:</strong> Catabolic states (severe trauma, burns), Bone marrow stimulation (aplastic anemia - historical), Osteoporosis.
                            <br><strong>Abuse:</strong> Used by athletes to increase muscle mass. Causes hepatotoxicity, aggression ("Roid rage"), sterility, cardiovascular damage.</p>

                            <h3>Drugs for Erectile Dysfunction</h3>
                            <p><strong>Sildenafil (Viagra), Tadalafil.</strong>
                            <br><strong>Mechanism:</strong> Inhibit <strong>PDE-5</strong> enzyme $\rightarrow$ increase cGMP in corpus cavernosum $\rightarrow$ smooth muscle relaxation $\rightarrow$ erection.
                            <br><strong>ADR:</strong> Headache, flushing, visual disturbances (blue vision - PDE6 inhibition).</p>
                            <div class="callout callout--danger">
                                <div class="callout-header">
                                    <span class="callout-icon">üö´</span>
                                    <h4 class="callout-title">Contraindication</h4>
                                </div>
                                <div class="callout-content">
                                    <p><strong>Sildenafil is absolutely contraindicated with Nitrates.</strong> Potentiation of vasodilation causes severe, fatal hypotension.</p>
                                </div>
                            </div>

                            <h3>Antiandrogens</h3>
                            <div class="grid grid-2">
                                <div class="grid-item">
                                    <h4>5-Alpha Reductase Inhibitors</h4>
                                    <p><strong>Finasteride, Dutasteride.</strong>
                                    <br>Inhibit conversion of Testosterone to <strong>Dihydrotestosterone (DHT)</strong> (the potent androgen in prostate/skin).
                                    <br><strong>Uses:</strong> Benign Prostatic Hyperplasia (BPH), Male pattern baldness.</p>
                                </div>
                                <div class="grid-item">
                                    <h4>Receptor Antagonists</h4>
                                    <p><strong>Flutamide, Bicalutamide.</strong>
                                    <br>Block androgen receptors.
                                    <br><strong>Uses:</strong> Prostate Cancer (combined with GnRH agonists to block "flare").
                                    <br><strong>Cyproterone acetate:</strong> Progestin with antiandrogenic activity. Used for hirsutism, precocious puberty.</p>
                                </div>
                            </div>
                        </div>
                    </section>
                    <!-- END: Chapter 69 -->

                    <!-- START: Chapter 70 -->
                    <section class="content-section" id="chapter-70">
                        <div class="section-header">
                            <div class="section-number">70</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü¶¥</span>
                                Calcium, Phosphorus, Vitamin D and Bisphosphonates
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Hormonal Regulation</h3>
                            <ul>
                                <li><strong>Parathyroid Hormone (PTH):</strong> Increases plasma $Ca^{++}$ (Bone resorption, Renal reabsorption, Vit D activation). Decreases plasma Phosphate.</li>
                                <li><strong>Vitamin D (Calcitriol):</strong> Increases plasma $Ca^{++}$ and Phosphate (increases intestinal absorption).</li>
                                <li><strong>Calcitonin:</strong> Decreases plasma $Ca^{++}$ (inhibits bone resorption).</li>
                            </ul>

                            <h3>Pharmacological Agents</h3>
                            
                            <h4>1. Vitamin D Preparations</h4>
                            <p><strong>Cholecalciferol (D3), Ergocalciferol (D2).</strong>
                            <br><strong>Calcitriol ($1,25(OH)_2 D_3$):</strong> Active form. Used in renal osteodystrophy (where kidney cannot activate D3) and hypoparathyroidism.</p>

                            <h4>2. Bisphosphonates</h4>
                            <p><strong>Alendronate, Risedronate (Oral); Zoledronic acid, Pamidronate (IV).</strong>
                            <br><strong>Mechanism:</strong> Bind to hydroxyapatite crystals in bone and inhibit <strong>osteoclast</strong> activity (inhibit bone resorption).
                            <br><strong>Uses:</strong> Osteoporosis (Postmenopausal, Steroid-induced), Paget's disease, Hypercalcemia of malignancy.
                            <br><strong>ADR:</strong> Esophagitis (Oral agents - must take with water and stand upright for 30 min), Osteonecrosis of the jaw (rare, high dose).</p>

                            <h4>3. Other Agents</h4>
                            <p><strong>Teriparatide:</strong> Recombinant PTH. Intermittent low doses stimulate <strong>osteoblasts</strong> (anabolic effect on bone). Used for severe osteoporosis.
                            <br><strong>Cinacalcet:</strong> Calcimimetic. Increases sensitivity of calcium-sensing receptor. Used in secondary hyperparathyroidism.
                            <br><strong>Sevelamer:</strong> Phosphate binder. Used in chronic renal failure.</p>

                            <div class="callout callout--info">
                                <div class="callout-header">
                                    <span class="callout-icon">üöë</span>
                                    <h4 class="callout-title">Management of Hypercalcemia</h4>
                                </div>
                                <div class="callout-content">
                                    <ol>
                                        <li><strong>Saline Rehydration:</strong> IV Normal Saline (Critical first step).</li>
                                        <li><strong>Loop Diuretics (Furosemide):</strong> Increases Ca++ excretion (only after rehydration).</li>
                                        <li><strong>Bisphosphonates (Zoledronate):</strong> Potent, long-acting inhibition of resorption.</li>
                                        <li><strong>Calcitonin:</strong> Rapid but short-lived effect.</li>
                                    </ol>
                                </div>
                            </div>
                        </div>
                    </section>
                    <!-- END: Chapter 70 -->
                </main>

                <nav class="document-nav">
                    <div class="nav-container">
                        <a href="section-13.html" class="nav-button nav-button--large nav-button--previous">
                            <div class="nav-label">Previous</div>
                            <div class="nav-title">Section XIII (Part A): Endocrine</div>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span>13b</span>
                                <span class="progress-separator">/</span>
                                <span>16</span>
                            </div>
                        <a href="../index.html" class="nav-button nav-button--large">
                            <div class="nav-label">Go to</div>
                            <div class="nav-title">Index</div>
                        </a>
                            <div class="progress-bar-container">
                                <div class="progress-bar-fill" style="width: 87.5%;"></div>
                            </div>
                            <div class="progress-label">Section 13 (Part B) of 16</div>
                        </div>
                        
                        <a href="section-14.html" class="nav-button nav-button--large nav-button--next">
                            <div class="nav-label">Next</div>
                            <div class="nav-title">Section XIV: Skin & Eye</div>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>